Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments

In line with its strategic priorities and growth ambitions, the board of directors of Gimv has decided to focus on investments and value creation in Anchor and in the following four investment platforms: Consumer, Healthcare, Smart Industries and Sustainable Cities. Gimv sees significant growth opportunities for these investments in a digital transition.

Gimv will not be making any further new investments in the Life Sciences platform. The existing Life Sciences portfolio, consisting of 11 companies that represent around 5% of the total Gimv portfolio value, will be retained and managed with a view to further maximising value, in consultation with the companies concerned and the respective syndicate investors.

The composition of the executive committee of Gimv will be reviewed accordingly. Gimv will initiate conversations with the members of the Life Sciences team.

During the past 45 years, Gimv has invested in the development of the Flemish and European Life Sciences sector. Gimv would like to thank everyone who has contributed to this.

Gimv will publish its results for the shortened financial year 2025 (9 months) on Thursday 19 February.